Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



Benefits of universal flu vaccination highlighted in new study

Universal vaccination against the flu could help slow the spread of the disease in the future, according to a recent study into the efficacy of flu vaccines. The clinical trial conducted by GlaxoSmithKline (GSK) examined the efficacy of Fluarix Tetra (inactivated quadrivalent influenza vaccine...

Read More

Which New Generic Drugs will be in US Pharmacies in 2018?

Last year was a record-breaking year for generic drug approvals in the United States. The US Food and Drug Administration (FDA) approved 1,027 generic drugs, 843 of which were full approvals, with tentative approvals making up the remainder. Tentative approvals are generic drugs considered ready...

Read More

Antiviral drug Acyclovir recalled due to product mix-up

Apace Packaging LLC has issued a nationwide voluntary recall of one lot of the antiviral medication acyclovir due to a product mix-up. Acyclovir is a widely used medication prescribed to treat several infections, notably infections caused by the herpes virus, such as genital herpes, cold sores,...

Read More

FluMist: Nasal influenza vaccine to return for 2018-19 flu season

Nasal influenza vaccines could be set to make a return for the 2018-19 flu season after a vaccine advisory group for the Centers for Disease Control and Prevention (CDC) voted to include FluMist in the immunization options for the coming year.  FluMist provides a route of administration for...

Read More

CDC recommends new shingles vaccine Shingrix

The Centers for Disease Control and Prevention (CDC) now formally recommends Shingrix (zoster vaccine recombinant, adjuvanted) as the vaccine of choice against shingles. It is only the second shingles vaccine to gain US Food and Drug Administration approval; the first was Merck’s drug...

Read More

Opiod cough medicines labeling changed to exclude pediatric use

In the latest step taken by the US Food and Drug Administration (FDA) to address the nation's opioid abuse epidemic, the agency has changed the indication of cough medicines containing opioids to exclude all pediatric patients.  Following the latest safety labeling changes, opioid cough and...

Read More

Top 5 Significant New Diabetes Drugs and Treatments in 2017

Diabetes is one of the most prevalent conditions in the United States, with figures from the Centers for Disease Control and Prevention suggesting almost one in ten people live with the condition, the equivalent to 30 million people across the country.  The majority of cases - nine out of ten...

Read More

Top 6 Important FDA Approvals from 2017

Over the course of 2017, the number of approvals granted by the US Food and Drug Administration (FDA) reached a 21-year high. More than 1,000 generic drugs were approved by the agency, according to FDA Commissioner Scott Gottlieb, MD, while first-time generic drug approvals numbered 74. Novel drug...

Read More

3 New Generic Drugs Available in US Pharmacies in 2018

Last month, the US Food and Drug Administration (FDA) announced plans to speed up the review process for generic drug applications, with the goal of providing patients with more generic medicine options. Generic drugs account for nine out of ten prescriptions in the United States, according to the...

Read More

Juluca: US pharmacies now stocking two-drug HIV treatment

Juluca (dolutegravir and rilpivirine), the first two-drug regimen for certain patients with HIV is now available in pharmacies across the United States. In November 2017, Viiv Healthcare, owned by pharmaceutical giant GlaxoSmithKline, gained US Food and Drug Administration (FDA) approval for...

Read More

FDA takes steps to speed up review of generic drug applications

The US Food and Drug Administration (FDA) has announced new measures to streamline its generic drug application review process. The agency is working to reduce the number of review cycles required for generic applications before they can be approved for use in the United States, FDA Commissioner...

Read More